The Carbohydrate Connection: Finding a Way to Target Alzheimer’s

The Carbohydrate Connection: Finding a Way to Target Alzheimer’s

Glyco-Net Press Release

GlycoNet Investigator Dr. Matthew Macauley is uncovering how carbohydrates influence immune cells in the brain and their impact on Alzheimer’s disease.

“About 10% of people make more of this shorter form and they have less of a chance of getting Alzheimer’s disease,” said Dr. Macauley.

The research team is working to understand why that’s the case, with the goal of leveraging that knowledge towards developing a therapeutic treatment for Alzheimer’s disease.

 “The fundamental nature of our findings is fine-tuning how we think about the best therapeutic modality to target CD33.” 

Territorial Acknowledgement

The University of Alberta, its buildings, labs, and research stations are primarily located on the traditional territory of Cree, Blackfoot, Métis, Nakota Sioux, Iroquois, Dene, and Ojibway/Saulteaux/Anishinaabe nations; lands that are now known as part of Treaties 6, 7, and 8 and homeland of the Métis. The University of Alberta respects the sovereignty, lands, histories, languages, knowledge systems, and cultures of First Nations, Métis and Inuit nations.

Scroll to Top